Skip to main content
. Author manuscript; available in PMC: 2010 Nov 1.
Published in final edited form as: Eur J Med Chem. 2009 May 24;44(11):4353–4361. doi: 10.1016/j.ejmech.2009.05.019

Figure 4.

Figure 4

In vitro proteasome-inhibitory activity of 1-3 in C4-2B cell extracts: (a) Proteasomal chymotrypsin-like activity (%CT) of the ligand HLI, the salt CuCl2, and an 1:1 HLI:CuCl2 mixture in DMSO at 25 mmol/L stock solution. (b) Concentration dependent inhibition by 1-3 at 0.1, 1, 5, 10, and 25 μM.